We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Videoendoscopic Drainage of Infected Pancreatic Collections

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00061269
Recruitment Status : Completed
First Posted : May 23, 2003
Last Update Posted : January 13, 2010
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Brief Summary:

The VARD (Videoendoscopic Assisted Retroperitoneal Drainage) approach as treatment for necrotizing pancreatitis proposes an alternative to standard complicated open abdomen treatment methods.

This treatment involves making a small incision and looking inside the abdomen with a videoendoscope. A videoendoscope is an instrument with a small camera and light on the end. It also has an extension tool that the surgeon can use to clean out any dead and infected tissue in the abdomen.

This approach may reveal a treatment opportunity with faster recovery potential and shorter hospitalizations for patients with necrotizing pancreatitis.


Condition or disease Intervention/treatment Phase
Pancreatitis, Acute Necrotizing Procedure: Videoscopic-Assisted Retroperitoneal Debridement (VARD) Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Study Start Date : September 2003

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pancreatitis
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
  • Pancreatic necrosis or peripancreatic fluid collection following acute pancreatitis noted on CT scan
  • Infected pancreatic necrosis or pancreatic abscess and determined by + FNA (gram stain or culture), as defined by the Atlanta Symposium
  • Not neutropenic or pregnant
  • No prior necrosectomy
  • No pancreatic pseudocyst, either sterile or infected

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00061269


Locations
United States, Oregon
Oregon Health Sciences University
Portland, Oregon, United States, 97239
Veteran's Administration-Portland
Portland, Oregon, United States, 97239
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 98104
Veteran's Administration Puget Sound
Seattle, Washington, United States, 98108
University of Washington
Seattle, Washington, United States, 98195
Canada, Ontario
University of Toronto
Toronto, Ontario, Canada
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

ClinicalTrials.gov Identifier: NCT00061269     History of Changes
Other Study ID Numbers: VDIPC (completed)
First Posted: May 23, 2003    Key Record Dates
Last Update Posted: January 13, 2010
Last Verified: January 2010

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Infected pancreatic necrosis

Additional relevant MeSH terms:
Pancreatitis
Pancreatitis, Acute Necrotizing
Pancreatic Diseases
Digestive System Diseases